Acidic extracellular pH is a major feature of tumor tissue, extracellular acidification being primarily considered to be due to lactate secretion from anaerobic glycolysis. Clinicopathological evidence shows that transporters and pumps contribute to H+ secretion, such as the Na+/H+ exchanger, the H+-lactate co-transporter, monocarboxylate transporters, and the proton pump (H+-ATPase); these may also be associated…
Cancer Cell International Template
Write in a clean editor, then format for Cancer Cell International in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Cancer Cell International format
Cancer Cell International is a peer-reviewed journal published by BMC (BioMed Central), covering Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Ferroptosis and cancer prognosis. Over its lifetime it has published 4,862 papers, which have received 130,723 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Cancer Cell International. 2023;12(3):45–58.
Formats any DOI in Cancer Cell International style. No sign-up. |
| Publishes research in | Cancer-related molecular mechanisms research MicroRNA in disease regulation Ferroptosis and cancer prognosis Circular RNAs in diseases Cancer Cells and Metastasis |
| ISSN | 1475-2867 |
| Citation impact (2-yr) | 5.74 |
| h-index | 117 |
| i10-index | 3,185 |
| Article processing charge | $2,440 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Nanjing Medical University |
| Journal website | cancerci.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Cancer Cell International per year
Citation impact of Cancer Cell International by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Cancer Cell International
Hypoxia is a common feature of solid tumors, and develops because of the rapid growth of the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of abnormal blood vessels supplying the tumor. It has been reported that tumor hypoxia can: activate angiogenesis, thereby enhancing invasiveness and risk of metastasis;…
Cancer chemotherapy resistance (MDR) is the innate and/or acquired ability of cancer cells to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in cancer therapy. Chemotherapy resistance can arise due to several host or tumor-related factors. However, most current research is focused on tumor-specific factors and specifically genes that…
In recent years, there has been a tremendous and growing interest among researchers to investigate the role of mircoRNA (miRNA) in normal cellular as well as in disease processes. miRNAs are a family of small non-coding RNAs which were reported to regulate the expression of various oncogenes or tumor suppressor genes. The expression profiling of…
The p53 protein is a transcription factor known as the "guardian of the genome" because of its critical function in preserving genomic integrity. The TP53 gene is mutated in approximately half of all human malignancies, including those of the breast, colon, lung, liver, prostate, bladder, and skin. When DNA damage occurs, the TP53 gene on…